What’s new

Oxford Cancer Biomarkers appoints Nick McCooke as its CEO

Oxford Cancer Biomarkers has appointed Nick McCooke as CEO, a key growth milestone for the company which aims to benefit

Read More

Quintiles Forms New Biomarker Research and Development Company

Professors David Kerr and Nick La Thangue offer oncology consulting and biomarker R&D activities spun out from the University of

Read More